HU186539B - Process for producing 1-bracket-1-cyclohexenyl-methyl-bracket closed-2-bracket-2-chloroethyl-bracket closed-pyrrolidine - Google Patents
Process for producing 1-bracket-1-cyclohexenyl-methyl-bracket closed-2-bracket-2-chloroethyl-bracket closed-pyrrolidine Download PDFInfo
- Publication number
- HU186539B HU186539B HU822217A HU221782A HU186539B HU 186539 B HU186539 B HU 186539B HU 822217 A HU822217 A HU 822217A HU 221782 A HU221782 A HU 221782A HU 186539 B HU186539 B HU 186539B
- Authority
- HU
- Hungary
- Prior art keywords
- bracket
- closed
- pyrrolidine
- cyclohexenylmethyl
- chloroethyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 title claims description 3
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 6
- -1 1-bromomethyl Chemical group 0.000 claims description 4
- UDQPNFMDGUZGKS-UHFFFAOYSA-N 2-(2-chloroethyl)-1-(cyclohexen-1-ylmethyl)pyrrolidine Chemical compound ClCCC1CCCN1CC1=CCCCC1 UDQPNFMDGUZGKS-UHFFFAOYSA-N 0.000 claims description 3
- YVVDLGCKVSBGRM-UHFFFAOYSA-N 3-(cyclohexen-1-yl)-2-pyrrolidin-1-ylpropan-1-ol Chemical compound C1CCCN1C(CO)CC1=CCCCC1 YVVDLGCKVSBGRM-UHFFFAOYSA-N 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- PDKVWCYJNKLAGE-UHFFFAOYSA-N 1-(bromomethyl)cyclohexene Chemical compound BrCC1=CCCCC1 PDKVWCYJNKLAGE-UHFFFAOYSA-N 0.000 description 3
- JZXVADSBLRIAIB-UHFFFAOYSA-N 2-pyrrolidin-2-ylethanol Chemical compound OCCC1CCCN1 JZXVADSBLRIAIB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- CRPKIZXDTOMBDB-UHFFFAOYSA-N 1-[1-chloro-3-(cyclohexen-1-yl)propan-2-yl]pyrrolidine Chemical compound C1CCCN1C(CCl)CC1=CCCCC1 CRPKIZXDTOMBDB-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- UHSJVJNPESREMO-UHFFFAOYSA-N 2-[1-(cyclohexen-1-ylmethyl)pyrrolidin-2-yl]ethanol Chemical compound OCCC1CCCN1CC1=CCCCC1 UHSJVJNPESREMO-UHFFFAOYSA-N 0.000 description 1
- 206010061307 Neck deformity Diseases 0.000 description 1
- FKCMADOPPWWGNZ-YUMQZZPRSA-N [(2r)-1-[(2s)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic acid Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O FKCMADOPPWWGNZ-YUMQZZPRSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/08—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
A találmány tárgya eljárás a (II) képletű pirrolidin származék előállítására
A találmány szerinti eljárás úgy végezzük, hogy 2-(2-pírrolidinil)-etanolt 1 -bróm-metil-ciklohexénnel reagáltatunk, majd a kapott 1-ciklohexenil-metil-2-hidroxi-etil-pirrolidint tionil-kloriddal melegítés közben reagáltatnak.
A találmány szerinti eljárással előállított vegyület az (I) általános képletű származékok előállításához használhatók fel. Az (I) általános képletű vegyületek helyi érzéstelenítő hatással rendelkeznek. Az (I) általános képletben m értéke - vagy 2 n értéke - vagy 2 azzal a feltétellel, hogy m és n összege 2,
A jelentése hidrogénatom, 1—4 szénatomos alkil-csoport,
X jelentése halogénatom, Így fluor-, klór-, vagy brómatom,
R jelentése ciklohexenil-metil-csoport.
|—ÍCHíb —|
A (/) ch2ch2ci (10
186.539
A találmány tárgya eljárás a (II) képletü l-(ciklohexenil-metil)-2-(2-klói-etil)-plrrolidin előállítására. E vegyület közbenső termékként használható az (1) általános képletü vegyületek előállításánál. Az (1) általános képletü vegyületek helyi érzéstelenítő hatást mutatnak.
Az (I) általános képletben m értéke 0 vagy 2 n értéke 0 vagy 2 azzal a feltétellel, hogy m és n összege 2,
A jelentése hidrogénatom, 1 -4 szénatomos alkilcsoport,
X jelentése halogénatom, így fluor-, klór- vagy brómatom,
R jelentése ciklohexenil-metil-csoport.
A találmány szerinti eljárást úgy végezzük, hogy 2-(2-pirrolidinil)-etanol 1 -b’róm-metil-ciklohexénnel reagáltatunk, majd az így kapott 1-ciklohexenil-metjl-2-hidroxi-etil-pirrolidint tionjl-kloriddal melegítés közben reagáltatjuk, amikoris 1-ciklohexenil-metil-2-klór-etil-pirrolidint kapunk.
Az így kapott (II) képletü 1-ciklohexenil-metil-2-klóretil-pirrolidint az (I) általános képletü vegyültek előállításához használjuk fel,
A találmány szerinti megoldást az alábbi példák szemléltetik.
1. példa
1.2-[ 1 -(1 -ciklohexeniI-metil)-2-pirrolidin]-e tanol
16,4 g 2-(2-piriOlidinil)-etanol (0,143 mól) és 84,3 ml 1,78 n alkoholos kálrium-hidroxidot (0,150 mól) 500 ml-es rövidnyakú gömblombikba viszünk, a lombik keverővei, hőmérővel és visszafolyató hűtővel, továbbá egy csepegtető tölcsérrel van ellátva. A lombikba 28 g 1-brúm-metil-ciklohexént (tisztasága 90%os) csepegtetünk,
A hőmérséklet 20 ’C-ról 55 °C-ra megy fel, amikoris csapadék képződik. Az egy óra hosszat tartó reakció lefutása után a keletkező sókat leszűrjük, a szűrletet szárazra pároljuk. Az olajos maradékot 150 ml vízzel, majd sósavval kezeljük, mindaddig, mig a pH értéke 1 nem lesz. 100—100 ml etil-éterrel a szűrletet kétszer extraháljuk, a vizes fázist nátrium-karbonát oldattal meglúgosítjuk, ezután 100 ml éténél extraháljuk, az egyesített extraktumokat magnéziumszulfát felett szárítjuk, szüljük, majd szárazra pároljuk. A visszamaradó olajos anyagot vákuumban desztilláljuk. Ilymódon 20,7 g cím szerinti vegyületet kapunk. 2 Hgmm mellett a forráspont: 100-107 °C, η2θ = 1,506.
Ί. példa
2-[ 1 {1 -ciklohexenil-metil)-2-pirrolidinil]-klóretán
17,8 g 2-[l-(l-ciklohexenil-metil)-2-pirrolidinil]etanolt (0,085 mól) 50 ml kloroformhoz adunk, a műveletet 250 ml-es rövidnyakú gömblombikban végezzük. A gömblombik hőmérővel,, keverővei, viszszafolyató hűtővel és csepegtető' tölcsérrel van ellátva. Ezt követően 15,3 ml tionil-kloridot csepegtetünk az elegyhez, miközben az elegy hőmérsékletét hűtés segítségével 20-25 °C-on tartjuk.
Az elegyet ezután 3 óra hosszat visszafolyató hűtő alatt forraljuk. Az oldatot szárazra bepároljuk, majd a maradékot 20 ml toluollal kezeljük. Az elegyet vákuumban szárazra pároljuk, majd a maradékot 100 ml etil-acetátban szuszpend&juk. A keletkezett kristályokat leszűrjük, majd 50 °C-os hőmérsékleten szárító szekrényben megszárítjuk.
19,4 cím szerinti vegyületet kapunk, op: 122 °C.
Claims (1)
- θθ Szabadalmi igénypont1. Eljárás a (II) képletü 1 -(ciklohexenil-metil)-2-(2-klór-etil)-pirrolidin előállítására, azzal j e 1 le m e z v e , hogy 2-(2-pirrolidin)-etanolt 1-bróm-metil-ciklohexénnel reagáltatunk, majd a kapott 1gg -ciklohexenil-metil-2-hidroxi-etil-pirroUdint tionil-klo· riddal melegítés közben reagáltatjuk.»1 db rajzKiadja: Országos Találmányi Hivatal Felelős kiadó: Hlmer Zoltán o.v.KÓDEX-2186539Nemzetközi osztályozás: C 07 D 207/08 (CH^b - | O-ICH^—CH-(CH2ln—N
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7917610A FR2460935A1 (fr) | 1979-07-06 | 1979-07-06 | Nouvelles phenoxyamines heterocycliques substituees, leur methode de preparation et leur application comme anesthetiques locaux |
| FR8007352A FR2479218A2 (fr) | 1980-04-01 | 1980-04-01 | Nouvelles phenoxyamines heterocycliques substituees, leur methode de preparation et leur application comme anesthesiques locaux |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU186539B true HU186539B (en) | 1985-08-28 |
Family
ID=26221244
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU80801658A HU181147B (en) | 1979-07-06 | 1980-07-03 | Process for preparing substituted heterocyclin phenoxamines |
| HU822217A HU186539B (en) | 1979-07-06 | 1980-07-03 | Process for producing 1-bracket-1-cyclohexenyl-methyl-bracket closed-2-bracket-2-chloroethyl-bracket closed-pyrrolidine |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU80801658A HU181147B (en) | 1979-07-06 | 1980-07-03 | Process for preparing substituted heterocyclin phenoxamines |
Country Status (37)
| Country | Link |
|---|---|
| US (1) | US4379161A (hu) |
| EP (2) | EP0024960B1 (hu) |
| JP (2) | JPS5639065A (hu) |
| AR (1) | AR224012A1 (hu) |
| AT (2) | ATE10739T1 (hu) |
| AU (2) | AU536482B2 (hu) |
| BE (1) | BE884124A (hu) |
| BG (2) | BG35039A3 (hu) |
| CA (1) | CA1163273A (hu) |
| CH (2) | CH655100A5 (hu) |
| CS (1) | CS216933B2 (hu) |
| DD (2) | DD201141A5 (hu) |
| DE (2) | DE3069789D1 (hu) |
| DK (1) | DK157538C (hu) |
| ES (1) | ES493111A0 (hu) |
| FI (2) | FI74274C (hu) |
| GR (1) | GR69638B (hu) |
| HK (2) | HK55689A (hu) |
| HU (2) | HU181147B (hu) |
| IE (2) | IE50061B1 (hu) |
| IL (2) | IL60472A (hu) |
| IN (2) | IN153037B (hu) |
| IT (1) | IT1188985B (hu) |
| JO (1) | JO1077B1 (hu) |
| LU (1) | LU82584A1 (hu) |
| MA (1) | MA18893A1 (hu) |
| MX (2) | MX6366E (hu) |
| NO (2) | NO156086C (hu) |
| NZ (1) | NZ194230A (hu) |
| OA (1) | OA06561A (hu) |
| PH (1) | PH16449A (hu) |
| PL (1) | PL127393B1 (hu) |
| PT (1) | PT71482A (hu) |
| RO (2) | RO81532B (hu) |
| SU (1) | SU1085507A3 (hu) |
| YU (2) | YU42344B (hu) |
| ZW (1) | ZW15280A1 (hu) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2586018B1 (fr) * | 1985-08-12 | 1988-03-25 | Ile De France | Nouveau benzodioxepanne, son procede de synthese et ses applications en therapeutique |
| WO1990012004A1 (en) * | 1989-04-07 | 1990-10-18 | Fujisawa Pharmaceutical Co., Ltd. | New naphthalene compounds and method of producing the same |
| EP0471941A3 (en) * | 1990-08-16 | 1992-10-14 | American Cyanamid Company | An improved process for the preparation of 5-bromo-2-methoxyresorcinol |
| US5472958A (en) * | 1994-08-29 | 1995-12-05 | Abbott Laboratories | 2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function |
| US7799337B2 (en) * | 1997-07-21 | 2010-09-21 | Levin Bruce H | Method for directed intranasal administration of a composition |
| WO1999024422A1 (en) * | 1997-11-05 | 1999-05-20 | Neurosearch A/S | Azaring-ether derivatives and their use as nicotinic ach receptor modulators |
| US8473062B2 (en) * | 2008-05-01 | 2013-06-25 | Autonomic Technologies, Inc. | Method and device for the treatment of headache |
| US8412336B2 (en) | 2008-12-29 | 2013-04-02 | Autonomic Technologies, Inc. | Integrated delivery and visualization tool for a neuromodulation system |
| US8494641B2 (en) | 2009-04-22 | 2013-07-23 | Autonomic Technologies, Inc. | Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism |
| US9320908B2 (en) * | 2009-01-15 | 2016-04-26 | Autonomic Technologies, Inc. | Approval per use implanted neurostimulator |
| US20100185249A1 (en) * | 2009-01-22 | 2010-07-22 | Wingeier Brett M | Method and Devices for Adrenal Stimulation |
| CN111205015B (zh) * | 2020-01-20 | 2021-11-26 | 东南大学 | 一种高稳定泡沫混凝土发泡剂的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE543876C (de) * | 1928-04-25 | 1932-02-11 | C H Boehringer Sohn Akt Ges | Verfahren zur Darstellung von Piperidinalkinen |
| US3117976A (en) * | 1958-11-12 | 1964-01-14 | Beecham Res Lab | Nu-alkyl-pyrrolidine-2-methanol, alpha cyclohexyl mandelates |
| FR1342756A (fr) * | 1958-11-21 | 1963-11-15 | Beecham Res Lab | Esters basiques et leur procédé de préparation, notamment le phényl-cyclohexyl-glycolate de (1-méthyl-2-pyrrolidyl) méthyle et ses sels d'addition |
| GB1096441A (en) * | 1964-01-15 | 1967-12-29 | Bristol Myers Co | Ethers of benzyl phenols and a process for the preparation thereof |
| US3904622A (en) * | 1968-02-16 | 1975-09-09 | Ile De France | Dialkylaminoalkyl ethers of 2-alkoxy-3,5-dihalobenzene |
| GB1268951A (en) * | 1969-06-12 | 1972-03-29 | Pfizer Ltd | Phenoxy-amines |
| FR2155927A1 (en) * | 1971-10-15 | 1973-05-25 | Synthelabo | 1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity |
| JPS5139661A (en) * | 1974-09-27 | 1976-04-02 | Nippon Kayaku Kk | Kogakukatsusei 11 mechiru 22 * beetaaa hidorokishechiru * pirorijin oyobisono chukantaino seizoho |
| JPS5251362A (en) * | 1975-10-20 | 1977-04-25 | Teijin Ltd | Preparation of optically active pyrrolidine derivatives |
| LU78625A1 (de) * | 1977-12-02 | 1979-06-13 | Byk Gulden Lomberg Chem Fab | Substituierte 1-phenyl-2-pyrrolidin-2-yl-ethanole,verfahren zu ihrer herstellung,ihre verwendung und sie enthaltende arzneimittel |
| DE2811952A1 (de) * | 1978-03-18 | 1979-10-31 | Merck Patent Gmbh | Phenoxyalkylamine und verfahren zu ihrer herstellung |
-
1980
- 1980-06-25 US US06/162,796 patent/US4379161A/en not_active Expired - Lifetime
- 1980-07-01 BG BG048341A patent/BG35039A3/xx unknown
- 1980-07-01 SU SU802938255A patent/SU1085507A3/ru active
- 1980-07-01 EP EP80400999A patent/EP0024960B1/fr not_active Expired
- 1980-07-01 YU YU1710/80A patent/YU42344B/xx unknown
- 1980-07-01 EP EP83105420A patent/EP0094102B1/fr not_active Expired
- 1980-07-01 AT AT80400999T patent/ATE10739T1/de not_active IP Right Cessation
- 1980-07-01 OA OA57149A patent/OA06561A/xx unknown
- 1980-07-01 CS CS804693A patent/CS216933B2/cs unknown
- 1980-07-01 AT AT83105420T patent/ATE17119T1/de not_active IP Right Cessation
- 1980-07-01 BG BG062115A patent/BG35746A3/xx unknown
- 1980-07-01 DE DE8080400999T patent/DE3069789D1/de not_active Expired
- 1980-07-01 DE DE8383105420T patent/DE3071314D1/de not_active Expired
- 1980-07-02 IL IL60472A patent/IL60472A/xx unknown
- 1980-07-02 BE BE1/9873A patent/BE884124A/fr not_active IP Right Cessation
- 1980-07-02 PT PT71482A patent/PT71482A/pt unknown
- 1980-07-02 AU AU60028/80A patent/AU536482B2/en not_active Ceased
- 1980-07-03 RO RO101590A patent/RO81532B/ro unknown
- 1980-07-03 HU HU80801658A patent/HU181147B/hu not_active IP Right Cessation
- 1980-07-03 NZ NZ194230A patent/NZ194230A/xx unknown
- 1980-07-03 RO RO110029A patent/RO85323B/ro unknown
- 1980-07-03 HU HU822217A patent/HU186539B/hu not_active IP Right Cessation
- 1980-07-03 AR AR281635A patent/AR224012A1/es active
- 1980-07-04 MA MA19091A patent/MA18893A1/fr unknown
- 1980-07-04 IE IE1653/85A patent/IE50061B1/en not_active IP Right Cessation
- 1980-07-04 PL PL1980225473A patent/PL127393B1/pl unknown
- 1980-07-04 MX MX80100439U patent/MX6366E/es unknown
- 1980-07-04 IE IE1392/80A patent/IE50060B1/en not_active IP Right Cessation
- 1980-07-04 ZW ZW152/80A patent/ZW15280A1/xx unknown
- 1980-07-04 DK DK289580A patent/DK157538C/da not_active IP Right Cessation
- 1980-07-04 GR GR62381A patent/GR69638B/el unknown
- 1980-07-04 CH CH5684/84A patent/CH655100A5/fr not_active IP Right Cessation
- 1980-07-04 CH CH5169/80A patent/CH648827A5/fr not_active IP Right Cessation
- 1980-07-04 IT IT49163/80A patent/IT1188985B/it active
- 1980-07-04 ES ES493111A patent/ES493111A0/es active Granted
- 1980-07-04 NO NO802027A patent/NO156086C/no unknown
- 1980-07-04 MX MX8011334U patent/MX7642E/es unknown
- 1980-07-04 LU LU82584A patent/LU82584A1/fr unknown
- 1980-07-04 FI FI802156A patent/FI74274C/fi not_active IP Right Cessation
- 1980-07-05 IN IN779/CAL/80A patent/IN153037B/en unknown
- 1980-07-05 JO JO19801077A patent/JO1077B1/en active
- 1980-07-07 DD DD80234984A patent/DD201141A5/de not_active IP Right Cessation
- 1980-07-07 DD DD222455A patent/DD153206A5/de unknown
- 1980-07-07 JP JP9321680A patent/JPS5639065A/ja active Granted
- 1980-07-07 PH PH24248A patent/PH16449A/en unknown
- 1980-09-30 JP JP13751280A patent/JPS5649351A/ja active Granted
-
1982
- 1982-12-16 CA CA000417963A patent/CA1163273A/fr not_active Expired
- 1982-12-17 YU YU2801/82A patent/YU42824B/xx unknown
-
1983
- 1983-06-01 IL IL68854A patent/IL68854A0/xx not_active IP Right Cessation
- 1983-10-10 IN IN1246/CAL/83A patent/IN158706B/en unknown
-
1984
- 1984-03-02 AU AU25260/84A patent/AU563009B2/en not_active Ceased
-
1986
- 1986-05-20 NO NO861988A patent/NO861988L/no unknown
-
1987
- 1987-07-03 FI FI872955A patent/FI872955A0/fi not_active Application Discontinuation
-
1989
- 1989-07-13 HK HK556/89A patent/HK55689A/xx unknown
- 1989-07-13 HK HK558/89A patent/HK55889A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL161379B1 (pl) | S p o só b wytwarzania kwasu 2-[2-[4-[/4-chlorofenylo/fenylom etylo]-1-piperazynylo] etoksy]octow ego i jego dichlorowodorku PL PL | |
| HU193161B (en) | Process for preparing new n-alkyl-norscopines | |
| HU186539B (en) | Process for producing 1-bracket-1-cyclohexenyl-methyl-bracket closed-2-bracket-2-chloroethyl-bracket closed-pyrrolidine | |
| JPH0456030B2 (hu) | ||
| IE52079B1 (en) | N-substituted omega-(2-oxo-4-imidazolin-1-yl)alkanoic acids,salts and esters thereof,process for producing the same and pharmaceutical preparations containing the same | |
| JPS5817454B2 (ja) | アルキル化ヒドロキシルアミン及びその製法 | |
| EA014530B1 (ru) | Способ получения фармацевтического промежуточного соединения | |
| WO2018185711A1 (en) | Solvates of eluxadoline | |
| SU786895A3 (ru) | Способ получени производных тиазолидин-,тиазан-или морфолинкарбоновых кислот или их кислотно-аддитивных солей | |
| JPH01156965A (ja) | チオヒダントイン化合物 | |
| SU588917A3 (ru) | Способ получени 1/2-( -нафтилокси)-этил/-3метилпиразолона-5 | |
| CA2148693A1 (en) | Tartronic acids, their acetalic ethers and o-esters | |
| SU841582A3 (ru) | Способ получени аминопроиз-ВОдНыХ АзидОфЕНОлА или иХ СОлЕй | |
| GB2036723A (en) | Mercaptoacylpiperazine carboxylic acid compounds | |
| JPS62155268A (ja) | ナイザチジンの合成法 | |
| SU1507763A1 (ru) | Рацемический 1-(2,4-дихлорфенокси)-3-(3,4-диметокси- @ -фенетиламино)-пропанол-2 или его гидрохлорид, обладающие гипотензивным действием | |
| GB2118553A (en) | Thiamorpholinones | |
| SU143810A1 (ru) | Способ получени n-алкоксипроизводных n'-бис-(бета-хлорэтил)-аминометилазобензола | |
| JP4234206B2 (ja) | テトラヒドロピリジン誘導体を調製する方法 | |
| JPH0559107B2 (hu) | ||
| KR940009533B1 (ko) | 헥사하이드로디벤조디옥산에서 유도된 암모늄염의 제조방법 | |
| US2856405A (en) | Mecuration products of 1-(2-pyrimidyl)-3-allylurea | |
| JPS6160673A (ja) | グアニジノチアゾ−ル誘導体の製造法 | |
| KR800001048B1 (ko) | 4-할로 메틸-2-피롤리디논의 제조방법 | |
| KR100311949B1 (ko) | 1-[(사이클로펜트-3-엔-1-일)메틸]-5-에틸-6-(3,5-다이메틸벤조일)-2,4-피리미딘다이온의제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HU90 | Patent valid on 900628 | ||
| HMM4 | Cancellation of final prot. due to non-payment of fee |